Medial EarlySign

Medial EarlySign Ltd is a healthcare technology company based in Kfar Malal, Israel, founded in 2009. The company specializes in developing AI-driven platforms designed to enhance clinical decision-making and disease management. Its primary offerings include AlgoMarkers and AlgoAnalyzer, predictive engines that utilize basic medical information, such as blood test results and electronic medical records, to identify risks associated with critical health threats. By analyzing extensive datasets from millions of patient records, Medial EarlySign aims to deliver actionable clinical insights that enable healthcare providers to predict outcomes related to cancers, metabolic, immune, and infectious diseases. These tools empower organizations to optimize care for individuals, facilitate proactive health management, and potentially reduce healthcare costs by improving patient outcomes and resource allocation.